Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742 in Healthy Adult Subjects
Clinical trial NCT03082235 · COMPLETED
Trial details
- NCT number
- NCT03082235
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-03
- Primary completion
- 2017-10-11
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.